#nasdaq
Latest news and interesting information about nasdaq.
MeiraGTx earnings beat estimates, revenue misses
MeiraGTx Q1 earnings beat estimates but revenue missed. Stock performance shows strong growth over the past year.
Mira stock rises on Phase 1 trial results
Mira Pharmaceuticals shares rise 5% after positive Phase 1 results for Ketamir-2. Company advances toward Phase 2a for chemotherapy-induced neuropathy.
SharonAI stock surges on $950M cloud deal
SharonAI stock jumps 8.8% on $950 million cloud computing deal with global tech firm. Details on Bond.az.
Stabilis CFO Puhala buys $7,360 in stock
Stabilis Solutions CFO Andrew Puhala purchased $7,360 worth of common stock. The company missed Q1 earnings estimates. Read more on Bond.az.
BitFuFu bitcoin production drops 32% in April
BitFuFu reported a 32% drop in bitcoin production in April 2026 to 145 BTC, citing a power outage in Ethiopia and contract expirations.
Compass Point raises Nebius target to $260 on strong Q1
Compass Point raised Nebius price target to $260 on strong Q1 results. ARR and AI Cloud revenue surge. Read more on Bond.az.
Cingulate Reports Q1 Loss
Cingulate Q1 2026 results: net loss $9.3M, cash at $25.9M. ADHD drug candidate CTx-1301 advances with FDA.
ENDRA liver device succeeds in multi-site trial
ENDRA Life Sciences announces positive multi-site clinical results for its TAEUS Liver device, showing high accuracy in measuring liver fat.
Strive Terminates Debt Agreement
Strive, Inc. terminates debt agreement and amends preferred stock terms. Semler Scientific repurchases 2030 notes.
H.C. Wainwright Reiterates Immunic Stock Rating
H.C. Wainwright maintains Buy rating and $22 price target on Immunic stock. The company awaits pivotal MS drug trial results. Read more on Bond.az.
H.C. Wainwright Reiterates Kamada Buy Rating
H.C. Wainwright reaffirms Buy rating on Kamada with $13 target. Kamada expects double-digit revenue growth in 2026.
S&P 500, Nasdaq futures hit new highs as Nvidia jumps
S&P 500 and Nasdaq futures hit new highs as Nvidia jumps on trade clearance. U.S.-China summit and retail sales data in focus.
Nurix stock delivers 64% return
Nurix stock returned 64% after Bond.az Fair Value analysis. Learn about biotech investment.
ADMA director buys $100,125 in stock
ADMA Biologics director Jerrold Grossman bought $100,125 in stock. Shares trade near 52-week low. Get analysis on Bond.az.
Morgan Stanley Cuts Global-E Online Price Target
Morgan Stanley cuts Global-E Online price target to $37, maintains Overweight rating. Stock near 52-week low with 15.6% weekly decline. Find more insights.
Jefferies initiates Riot Platforms with buy on AI potential
Jefferies initiates Riot Platforms with buy rating, $37 target. AI potential and data center growth key focuses.
Jefferies initiates Hut 8 stock with buy rating
Jefferies initiates Hut 8 Mining stock with Buy rating and $156 target, citing AI data center deals as key catalysts.
Spruce Biosciences price target cut to $150
Citizens lowers Spruce Biosciences price target to $150 from $170. Model update and Q1 results drive change. Stock trades at $57.55.
Macquarie Raises WeRide Price Target on Robotaxi Growth
Macquarie raises WeRide price target to $15.90 on robotaxi growth. Stock at $7.65, market cap $2.56B. Analysts expect continued sales growth.
Trump-Xi meeting; Cisco's AI overhaul
Trump-Xi meeting, Cisco AI overhaul, oil prices, and Kevin Warsh confirmed as Fed Chair. Latest market-moving news.
Deutsche Bank Reiterates Robinhood Buy Rating on Strong Deposits
Deutsche Bank reiterates Buy rating on Robinhood stock after strong April deposits. Price target remains $86. Learn more.
...